Ireland
--:--IST
Recruiting Observational

Follow-up of Adolescents With Autism and Psychotic Symptoms - Psychiatric Co-morbidity and Functional Impairment.

NCT07427810 · tracked via the Priya Life Science Sweden tracker
Sponsor
Värmland County Council, Sweden
Phase
Observational
Started
2026-07-13
Last updated
2026-09-02

Condition(s) studied

Autism DisorderSchizophrenia and Other Psychotic Disorders

Investigational drug(s) / intervention(s)

None. Observational study.

None. Observational study.: None. Observational study.

Study summary

Purpose: To describe level of function, psychotic and psychiatric symptoms in a 10-year follow up of individuals with autism and psychotic symptoms.

Method: A case-control study based on a cohort of 48 teenagers with autism established 2013. In this study, 22 participant reported psychotic symptom in self-evaluation questionnaires design for early detection.

An additional 5 individuals were recruited in a second round of recruitment in 2019. Three of these individuals reported psychotic symptoms.

We aim to recruit individuals with psychotic symptoms and controls from the same cohort without psychotic symptoms. Data will be collected from self-rating scales, clinical evaluation including semi-structured interviews and healthcare journals.

The study is primarily descriptive, with group comparison by non-parametric method.

Eligibility

Sex
ALL
Min age
20 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: * Age 15-18 at enrollment for the original study, * Autism spectrum disorder. * IQ\>70. Exclusion Criteria: \- Non.

Primary outcome measure(s)

  • Number of participants with psychotic disease — Single time point at enrollment

Trial sites (1)

FacilityCityRegionStatus
Karlstad central Hospital Karlstad Värmland County Recruiting

More Värmland County Council, Sweden trials in Sweden

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07427810 on ClinicalTrials.gov ↗ ← All trials in Sweden